Cargando…
Immunotherapy with artificial adjuvant vector cells: Harnessing both arms of the immune response
Both innate and adaptive immunity underpin cancer immunosurveillance. To stimulate both these arms of the immune system, we used allogeneic cells loaded with natural killer T (NKT) cell ligands and expressing tumor-associated antigens, resulting in NKT cell activation, dendritic-cell maturation and...
Autores principales: | Fujii, Shin-ichiro, Shimizu, Kanako |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654573/ https://www.ncbi.nlm.nih.gov/pubmed/23734303 http://dx.doi.org/10.4161/onci.23432 |
Ejemplares similares
-
Could the properties of IL-27 make it an ideal adjuvant for anticancer immunotherapy?
por: Swarbrick, Alexander, et al.
Publicado: (2013) -
Membrane-anchored chemokine fusion proteins: A novel class of adjuvants for immunotherapy
por: Nelson, Peter J, et al.
Publicado: (2013) -
Cancer immunotherapy using artificial adjuvant vector cells to deliver NY‐ESO‐1 antigen to dendritic cells in situ
por: Fujii, Shin‐ichiro, et al.
Publicado: (2022) -
Cell type specific gene delivery by lentiviral vectors: New options in immunotherapy
por: Zhou, Qi, et al.
Publicado: (2013) -
Moving ahead on harnessing synthetic lethality to fight cancer
por: Jerby-Arnon, Livnat, et al.
Publicado: (2015)